Whitener Capital Management, Inc. Gsk PLC Transaction History

Whitener Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$32.47 - $48.83 $140,108 - $210,701	-4,315 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $28,014 - $32,182	667 Added 18.28%	4,315 $202,000
Q3 2019 Nov 07, 2019	SELL	$40.46 - $43.52 $18,207 - $19,584	-450 Reduced 10.98%	3,648 $155,000
Q2 2019 Aug 02, 2019	SELL	$39.4 - $42.7 $25,610 - $27,755	-650 Reduced 13.69%	4,098 $164,000
Q4 2018 Feb 06, 2019	BUY	$37.8 - $42.69 $5,254 - $5,933	139 Added 3.02%	4,748 $181,000
Q3 2018 Nov 07, 2018	BUY	$39.75 - $42.69 $183,207 - $196,758	4,609 New	4,609 $185,000
Q2 2018 Aug 08, 2018	SELL	$39.61 - $42.76 $170,481 - $184,039	-4,304 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$36.18 - $40.15 $132,418 - $146,949	3,660 Added 568.32%	4,304 $168,000
Q4 2017 Apr 23, 2018	BUY	$35.34 - $41.9 $22,758 - $26,983	644	644 $22,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitener Capital Management, Inc. with notifications on news.